anastrozole has been researched along with Leiomyosarcoma, Epithelioid in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Uterine leiomyosarcoma metastatic to the lungs regressed with the use of the anastrozole aromatase inhibitor." | 3.74 | Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor. ( Burnett, AF; Hardman, MP; Roman, JJ; Santin, AD, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Edmondson, RJ | 1 |
| O'Connell, RL | 1 |
| Banerjee, S | 1 |
| Mileshkin, L | 1 |
| Sykes, P | 1 |
| Beale, P | 1 |
| Fisher, A | 1 |
| Bonaventura, A | 1 |
| Millan, D | 1 |
| Nottley, S | 1 |
| Benson, C | 1 |
| Hamilton, A | 1 |
| Sjoquist, K | 1 |
| Alexander, L | 1 |
| Kelly, C | 1 |
| Carty, K | 1 |
| Divers, L | 1 |
| Bradshaw, N | 1 |
| Friedlander, M | 1 |
| Altman, AD | 1 |
| Nelson, GS | 1 |
| Chu, P | 1 |
| Nation, J | 1 |
| Ghatage, P | 1 |
| Hardman, MP | 1 |
| Roman, JJ | 1 |
| Burnett, AF | 1 |
| Santin, AD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Endometrial Stromal Tumors: an Observational Study[NCT02829437] | 100 participants (Anticipated) | Observational | 2016-10-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for anastrozole and Leiomyosarcoma, Epithelioid
| Article | Year |
|---|---|
Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.
Topics: Adult; Anastrozole; Aromatase Inhibitors; Female; Humans; Hysterectomy; Leiomyosarcoma; Middle Aged; | 2012 |
1 trial available for anastrozole and Leiomyosarcoma, Epithelioid
| Article | Year |
|---|---|
Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903).
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Carcinosarcoma; Female; Humans; L | 2021 |
1 other study available for anastrozole and Leiomyosarcoma, Epithelioid
| Article | Year |
|---|---|
Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromat | 2007 |